D

Alexandria Real Estate Equities, Inc. ARE

$53.52 $0.591.12% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a U.S.-based real estate investment trust (REIT) focused primarily on owning, operating, and developing collaborative life science, agtech, and advanced technology campuses. The company operates at the intersection of commercial real estate and scientific innovation infrastructure, serving biotechnology companies, pharmaceutical firms, academic research institutions, medical technology businesses, and government-related research organizations. ARE is widely recognized for specializing in laboratory and research environments that require highly technical infrastructure, differentiated regulatory compliance capabilities, and proximity to leading innovation ecosystems.

The company’s principal revenue drivers are rental income from long-term leases, property development activities, and strategic real estate investments tied to innovation clusters. ARE has developed a concentrated presence in major life science markets including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, and Research Triangle. Founded in 1994 by Joel S. Marcus, the company evolved from a niche life science landlord into one of the largest dedicated life science REITs in the United States through disciplined campus development, strategic acquisitions, and partnerships with research-driven tenants and institutions.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Monday, August 3, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
626 578 0777
Address
26 North Euclid Avenue
Pasadena, CA 91101-6104
Country
Year Founded

Headlines